Koers Hubei Hongyuan Pharmaceutical Technology Co., Ltd.
Aandelen
301246
CNE100005ZB9
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
17,94 CNY | +2,05% | +10,06% | -30,95% |
Omzet 2022 | 2,06 mld. 286 mln. 265 mln. | Omzet 2023 | 2,05 mld. 284 mln. 264 mln. | Marktkapitalisatie | 10,39 mld. 1,44 mld. 1,34 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | 435 mln. 60,2 mln. 55,9 mln. | Nettowinst (verlies) 2023 | 87 mln. 12,04 mln. 11,18 mln. | EV/omzet 2022 * | - |
Nettoliquiditeiten 2022 | 51,05 mln. 7,06 mln. 6,56 mln. | Nettoliquiditeiten 2023 | 1,83 mld. 253 mln. 235 mln. | EV/omzet 2023 | 4,17 x |
K/w-verhouding 2022 * |
-
| K/w-verhouding 2023 |
116
x | Werknemers | 2.075 |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
0,19% | Vrij verhandelbaar | 37,32% |
1 dag | +2,05% | ||
1 week | +10,06% | ||
Lopende maand | +10,06% | ||
1 maand | +0,96% | ||
3 maanden | -12,36% | ||
6 maanden | -35,88% | ||
Lopend jaar | -30,95% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Shuang Xi Xu
CEO | Chief Executive Officer | 58 | - |
Gao Liang Lei
CHM | Chairman | 59 | - |
Ke Feng Zeng
DFI | Director of Finance/CFO | 39 | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Qing Xie
BRD | Director/Board Member | 61 | - |
Si Yuan Cheng
BRD | Director/Board Member | 51 | - |
Guo Ping Yin
FOU | Founder | 64 | 21-01-02 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
10-05-24 | 17,94 | +2,05% | 25 233 370 |
09-05-24 | 17,58 | +2,75% | 17 360 230 |
08-05-24 | 17,11 | +2,33% | 12 261 910 |
07-05-24 | 16,72 | +0,24% | 5 520 625 |
slotkoers Shenzhen S.E., 10 mei 2024
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
-30,95% | 993 mln. | |
+30,38% | 684 mld. | |
+26,51% | 568 mld. | |
-4,36% | 361 mld. | |
+19,30% | 329 mld. | |
+3,73% | 284 mld. | |
+16,70% | 240 mld. | |
+8,78% | 208 mld. | |
-7,93% | 200 mld. | |
+7,68% | 166 mld. |